ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2056

$571K Total Retail Price of All Prescriptions

Rank: 39 out of 2056

560 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

3% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 12,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 1,045 996 1 6
SIMVASTATIN 597 577 2 2
LISINOPRIL 551 495 3 1
HYDROCHLOROTHIAZIDE 545 521 4 7
METFORMIN HCL 520 471 5 8
ALENDRONATE SODIUM 386 386 6 26
ENALAPRIL MALEATE 376 358 7 73
LOSARTAN POTASSIUM 346 346 8 13
GLIPIZIDE 326 303 9 39
LOVASTATIN 318 280 10 16
RANITIDINE HCL 312 311 11 22
TAMSULOSIN HCL 303 296 12 28
METOPROLOL TARTRATE 264 264 13 11
DIOVAN 255 255 14 68
METOPROLOL SUCCINATE 252 235 15 19
OMEPRAZOLE 247 210 16 4
WARFARIN SODIUM 215 205 17 12
CRESTOR 196 188 18 30
ATORVASTATIN CALCIUM 187 170 19 17
LIDODERM 158 158 20 99
FUROSEMIDE 156 156 21 9
ATENOLOL 154 145 22 10
ALLOPURINOL 153 131 23 32
TRIAMCINOLONE ACETONIDE 150 137 24 81
GABAPENTIN 137 127 25 14
ZOSTAVAX 124 117 26 110
ISOSORBIDE MONONITRATE ER 123 123 27 87
ACTOS 121 96 28 119
VOLTAREN 110 97 29 182
DOXAZOSIN MESYLATE 102 96 30 76
LANTUS 101 75 31 41
LEVOTHYROXINE SODIUM 97 90 32 3
FLUTICASONE PROPIONATE 96 96 33 31
PROAIR HFA 95 90 34 29
SPIRIVA 94 80 35 42
ZOLPIDEM TARTRATE 93 93 36 23
TRAZODONE HCL 86 62 37 21
CITALOPRAM HBR 84 78 38 15
CLOPIDOGREL 81 76 39 72
TRIAMTERENE-HCTZ 78 78 40 46
DONEPEZIL HCL 78 76 40 37
FINASTERIDE 76 76 42 90
SERTRALINE HCL 73 54 43 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 70 44 34
PRAVASTATIN SODIUM 69 64 45 20
TRAMADOL HCL 67 56 46 27
ADVAIR DISKUS 66 41 47 51
COLCRYS 61 52 48 223
CHLORTHALIDONE 58 49 49 94
HYDROCODONE-ACETAMINOPHEN 58 38 S3 49 5
NAMENDA 58 58 49 62
PLAVIX 54 51 52 131
INSULIN SYRINGE 53 38 53 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.